Company name
2022Founder
David Sinclair is a venture partner at Catalio Capital Management and a professor of genetics at Harvard Medical School, where he co-directs the Paul F. Glenn Labs for the Biology of Aging. He studies the biology of aging and has co-founded biotechnology companies including Sirtris Pharmaceuticals and Life Biosciences, and co-authored the book Lifespan.
Venture Partner
Professor of Genetics; Co-Director, Paul F. Glenn Labs for the Biology of Aging
Co-founder
Co-Founder
Co-Founder
Postdoctoral researcher